News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
147 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (3067)
February (2725)
March (2858)
April (2936)
May (3736)
June (2836)
July (2951)
August (2835)
September (2998)
October (3624)
November (3299)
December (2403)
Day
3 (215)
4 (180)
5 (170)
6 (141)
7 (103)
10 (147)
11 (151)
12 (140)
13 (131)
14 (99)
16 (1)
17 (130)
18 (150)
19 (147)
20 (135)
21 (98)
22 (2)
24 (173)
25 (145)
26 (138)
27 (137)
28 (103)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
3
4
5
6
7
10
11
12
13
14
16
17
18
19
20
21
22
24
25
26
27
28
Drug Development
Seattle Genetics, Inc. Announces Initiation of Phase 1/2 Trial of ADCETRIS® (Brentuximab Vedotin) in Combination With Bendamustine for Hodgkin Lymphoma Patients After Initial Relapse
June 10, 2013
·
1 min read
Policy
BioDelivery Sciences International Announces NDA Submission for BUNAVAIL on Track Following Positive Pre-NDA Meeting With FDA
June 10, 2013
·
5 min read
Business
Xenon Pharmaceuticals Inc. Licenses Antisense Drug XEN701 From Isis Pharmaceuticals, Inc. and Initiates Preclinical Toxicology Studies
June 10, 2013
·
6 min read
Genetown
Paragonix Technologies Inc., Announces Presentation of “An Innovative, Novel Hypothermic Storage System for Donor Hearts” During the 16th Congress of the ESOT in Vienna, Austria From September 8–11 2013
June 10, 2013
·
1 min read
BioMidwest
Clovis Oncology Announces Proposed Offering of Common Stock
June 10, 2013
·
1 min read
Biotech Bay
Ingenuity Systems Announces Significant Global Uptake of Variant Analysis Solution for Next-Generation Sequencing
June 10, 2013
·
1 min read
Genetown
AB SCIEX Drives 6500 Series to Top of Triple Quadrupole Market
June 10, 2013
·
1 min read
Pharm Country
Echo Therapeutics Submits Pre-Submission Package to FDA for Symphony® CGM System
June 10, 2013
·
4 min read
Prollenium Medical Technologies No. 292 on PROFIT 500 List 2013
June 10, 2013
·
2 min read
Drug Development
Boehringer Ingelheim Corporation’s Investigational Faldaprevir+ Achieved Viral Cure in 88% of Treatment-Naive Hepatitis C Patients in Asia
June 10, 2013
·
1 min read
Previous
3 of 15
Next